BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.

Cell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.

Quarterly Reviews of Biophysics, published by Cambridge University Press, is a premier academic journal dedicated to the field of biophysics. With an impressive impact factor reflecting its esteemed reputation, this journal occupies a distinguished position as evidenced by its Q1 category ranking in Biophysics and its ranking of #7 out of 152 in the Scopus database, placing it in the top 5% of its field. The journal has been a significant contributor to the scientific community since its inception in 1968, offering insightful reviews and analysis that bridge the disciplines of biochemistry, genetics, and molecular biology. Quarterly Reviews of Biophysics provides an invaluable platform for researchers, professionals, and students alike to access high-quality, peer-reviewed content that enhances understanding of molecular interactions and systems biology. While Open Access is not currently offered, the journal remains committed to disseminating critical knowledge to advance research and innovation in biophysics.

Methods and Protocols is a prestigious open-access journal published by MDPI, focusing on the critical domain of biochemistry, genetics, molecular biology, and biotechnology. Launched in 2018 and based in Basel, Switzerland, the journal provides a vital platform for sharing innovative methodologies and experimental protocols that advance scientific research and development. With an impressive Q2 ranking in multiple categories, including Biochemistry, Genetics and Molecular Biology, and Biotechnology, it fosters a collaborative environment for researchers and professionals to disseminate their findings. With a mission to enhance reproducibility and transparency in scientific inquiry, Methods and Protocols not only serves as an essential resource for academia but also contributes to the practical application of research in various industries. The journal's open-access model ensures that cutting-edge research is accessible to a global audience, thus promoting knowledge sharing and inspiring future innovations within the scientific community.

Bio-protocol is an innovative open-access journal dedicated to the advanced fields of biochemistry, immunology, neuroscience, and plant science, published by BIO-PROTOCOL in the United States since 2023. With an E-ISSN of 2331-8325, this journal serves as a pivotal platform for sharing high-quality methodologies and experimental protocols, enabling researchers, professionals, and students to streamline their experimental workflows and enhance reproducibility in scientific research. In 2023, Bio-protocol achieved notable rankings, placing in the Q2 category for biochemistry, genetics, molecular biology, and immunology, as well as Q3 in neuroscience, reflecting its growing influence and relevance in these fields. The journal offers full open access, ensuring that cutting-edge research is freely available, promoting global collaboration and innovation in the life sciences. Engaging with Bio-protocol positions its readers at the forefront of significant scientific advancements and methodological developments.

BMC Research Notes, published by SPRINGERNATURE, is a leading open-access journal dedicated to the dissemination of research notes across various disciplines, particularly within the fields of biochemistry, genetics, molecular biology, and medicine. Since its establishment in 2008, the journal has embraced a mission to facilitate the rapid publication of short, concise articles that contribute significantly to ongoing scientific dialogues. With an impact factor reflective of its reputation, BMC Research Notes ranks Q2 in Biochemistry, Genetics and Molecular Biology and holds a commendable Q3 classification in Medicine for 2023. Notably, the journal's Scopus rankings highlight its prominence, especially in General Medicine, where it stands in the 77th percentile. Situated in the United Kingdom, the journal prioritizes open access to foster transparency and engagement with a global audience, making it an essential resource for researchers, practitioners, and students who are looking to stay abreast of new findings and practical advancements within their fields. The journal continues to span evolving research themes from 2008 to 2024, ensuring a dynamic repository of knowledge in the rapidly advancing landscape of biomedical research.

NATURE, published by NATURE PORTFOLIO, stands as a premier academic journal in the field of multidisciplinary sciences, and has consistently ranked number one in its category, reflecting its influence and prestige with an impressive 99th percentile position among 171 journals in the Scopus rankings. With an illustrious history dating back to 1869, this journal serves as a critical platform for disseminating pioneering research and groundbreaking discoveries across a myriad of disciplines. While it maintains a traditional publishing model, NATURE's significance is underscored by its high impact factor, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of scientific advancements. The journal's headquarters are located in Berlin, Germany, and it continues to shape the scientific dialogue globally.

Scientific Reports, published by the esteemed NATURE PORTFOLIO, is a prominent multidisciplinary journal that has been making significant strides in scientific communication since its inception in 2011. With an impressive impact factor and ranked in the Q1 category of multidisciplinary journals, it holds a respected position, placing it at #14 out of 171 according to Scopus rankings, reflecting its high citation rates and robust academic contributions in the 92nd percentile. The journal operates under an Open Access model, enabling broad dissemination of research findings and advancing scientific knowledge globally. Based in the United Kingdom, with offices in Germany, Scientific Reports is committed to publishing high-quality, peer-reviewed research across diverse fields, catering to the needs of researchers, professionals, and students alike, fostering collaboration and innovation in the scientific community.

MethodsX is a premier peer-reviewed journal published by Elsevier, dedicated to advancing the field of applied methods across various disciplines, particularly in Clinical Biochemistry and Medical Laboratory Technology. Since its inception in 2014, this Open Access journal has fostered innovation by allowing researchers to share and access high-quality methodologies designed to enhance reproducibility and effectiveness in research practices. Based in the Netherlands, MethodsX has achieved an impressive ranking in the Scopus database, placing in the top 78th percentile among multidisciplinary journals. The journal is committed to providing researchers, professionals, and students with a platform to disseminate new techniques and strategies, ensuring that groundbreaking methods are readily available to the global scientific community. With a focus on fostering collaboration and interdisciplinary research, MethodsX aims to bridge gaps across various scientific domains and empower future advancements until its converged years in 2024.